Zweig DiMenna Associates LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 35.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 80,631 shares of the healthcare conglomerate’s stock after buying an additional 20,900 shares during the period. Zweig DiMenna Associates LLC’s holdings in UnitedHealth Group were worth $13,224,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Patriot Financial Group Insurance Agency LLC raised its stake in UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares during the last quarter. Cribstone Capital Management LLC raised its stake in UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 125 shares during the last quarter. Thomas J. Herzfeld Advisors Inc. acquired a new stake in UnitedHealth Group during the fourth quarter worth $111,000. Parkside Financial Bank & Trust raised its stake in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares during the last quarter. Finally, Israel Discount Bank of New York GFN acquired a new stake in UnitedHealth Group during the fourth quarter worth $139,000. 86.21% of the stock is owned by institutional investors and hedge funds.
Shares of UnitedHealth Group Incorporated (NYSE UNH) traded down 0.98% on Friday, hitting $190.82. 2,858,501 shares of the company were exchanged. The company has a 50-day moving average price of $190.49 and a 200 day moving average price of $175.87. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $196.04. The firm has a market cap of $184.50 billion, a P/E ratio of 22.92 and a beta of 0.64.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. During the same quarter last year, the company earned $1.96 earnings per share. UnitedHealth Group’s revenue for the quarter was up 7.7% on a year-over-year basis. Analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be given a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.57%. The ex-dividend date is Thursday, September 7th. UnitedHealth Group’s dividend payout ratio (DPR) is 35.13%.
WARNING: “UnitedHealth Group Incorporated (UNH) Shares Bought by Zweig DiMenna Associates LLC” was published by BNB Daily and is the sole property of of BNB Daily. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at https://www.baseball-news-blog.com/2017/08/19/zweig-dimenna-associates-llc-buys-20900-shares-of-unitedhealth-group-incorporated-unh-updated-updated-updated.html.
A number of analysts have recently weighed in on UNH shares. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday, May 19th. Deutsche Bank AG reiterated a “buy” rating and issued a $187.00 price objective (up previously from $183.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Cantor Fitzgerald restated an “overweight” rating and set a $208.00 price target on shares of UnitedHealth Group in a research report on Friday, July 21st. Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 price target on the stock in a research report on Tuesday, May 30th. Finally, CIBC raised their price target on shares of UnitedHealth Group from $186.00 to $187.00 and gave the company an “outperform” rating in a research report on Monday, April 24th. One analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $203.41.
In other news, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the sale, the director now owns 75,735 shares of the company’s stock, valued at $13,832,240.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total transaction of $990,219.60. Following the completion of the transaction, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. Insiders sold 15,540 shares of company stock valued at $2,873,320 in the last ninety days. 0.89% of the stock is owned by corporate insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.